首页> 外文期刊>Infection >Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis
【24h】

Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis

机译:基于系列干扰素-γ释放测定法(IGRA)的接触调查对暴露于肺结核患者的血液肿瘤科病房的儿童

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Interferon-gamma release assays (IGRAs) have high specificity and sensitivity for the diagnosis of tuberculosis (TB) infection. However, their role as a screening tool in children with immunodeficiency disorders is still unclear. In the present study, we performed a contact investigation using serial IGRAs on children with immunodeficiency conditions exposed to a contagious TB patient. Methods: Children who were exposed to a contagious TB case underwent serial QuantiFERON? TB Gold In-Tube (QFT-GIT) and T-SPOT ?.TB (T-SPOT) testing. Results: Eighteen children were tested. At the first testing, only two children (11 %) were positive to T-SPOT. Indeterminate results were more frequent with QFT-GIT (35 %) than with T-SPOT (12 %). In the multivariable analysis, a statistically significant association of lymphocyte count 500 cells/mm3 (p 0.00005) and low age (p = 0.03) with indeterminate results for the QFT-GIT test but not for T-SPOT (p = 0.10 and p = 0.88, respectively) was found. At the end of October 2012, 15 of the 18 children were alive and none developed active TB disease. Conclusion: T-SPOT provided more determinate results and was less influenced by low age and lymphocytopenia than QFT-GIT in this population of immunodeficient children. These findings suggest that T-SPOT is a more accurate test for the identification of TB infection in young children with lymphocytopenia and should be preferred to QFT-GIT under such specific conditions.
机译:背景:γ-干扰素释放测定法(IGRA)对结核(TB)感染的诊断具有很高的特异性和敏感性。然而,它们作为免疫缺陷疾病患儿筛查工具的作用仍不清楚。在本研究中,我们使用连续IGRA对接触过传染性结核病患者的免疫缺陷病患儿进行了接触调查。方法:暴露于传染性结核病例的儿童接受了系列QuantiFERON治疗? TB金管(QFT-GIT)和T-SPOT?.TB(T-SPOT)测试。结果:18名儿童进行了测试。在第一次测试中,只有两个孩子(11%)对T-SPOT呈阳性。 QFT-GIT(35%)比T-SPOT(12%)的结果不确定。在多变量分析中,对于QFT-GIT测试,淋巴细胞计数<500个细胞/ mm3(p <0.00005)和低龄(p = 0.03)的统计学显着性与不确定的结果相关,而对于T-SPOT则不明显(p = 0.10和分别找到p = 0.88)。截至2012年10月,这18名儿童中有15名还活着,没有一人患上活动性结核病。结论:与QFT-GIT相比,在这一免疫缺陷儿童人群中,T-SPOT提供了更确定的结果,并且受低年龄和淋巴细胞减少的影响较小。这些发现表明,T-SPOT是一种更准确的检测方法,可用于识别患有淋巴细胞减少症的幼儿中的TB感染,在这种特定条件下,应首选Q-GIT代替T-SPOT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号